CTRI/2022/04/042113Not yet recruiting未知
oninvasive treatment of recalcitrant keloids with contact brachytherapy using customized Yttrium-90 skin patch: A pilot study
Trial Snapshot
- Phase
- 未知
- Status
- Not yet recruiting
- Sponsor
- JIPMER
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •All patients whose age is more than 18 years with recalcitrant keloid of size between 1mm to 5 cm who have undergone treatment for at least one year and last treatment should have been received before 3 months Only one or two lesions should be included in that patient
Exclusion Criteria
- •1. Recalcitrant keloids present in the face.
- •2. All pregnant and lactating women.
- •3. Patients treated within 3 months
Investigators
Similar Trials
Not yet recruiting
Phase 4
Intralesional bleomycin treatment of keloids using an electronic pneumatic jet injector: a double-blind randomized, placebo-controlled trial with split-lesion desigNL-OMON54897Erasmus MC, Universitair Medisch Centrum Rotterdam14
Active, not recruiting
Phase 1
Research into a novel treatment for excessive scarring using needleless injection.KeloidsEUCTR2020-003228-18-NLErasmus MC15
Completed
Phase 3
Investigation of the Keloid treatment results using plasma device combined with or without triamcinolone injectioIRCT20230801058997N1Islamic Azad University20
Completed
Phase 1
Treatment of Keloids and Hypertrophic Scars with a Long-pulsed Nd:YAG Laser in non-contact modekeloids and hypertrophic scarsJPRN-UMIN000001208Plastic, Reconstructive and Aesthetic Surgery, Nippon Medical School20
Completed
Not Applicable
Outpatient Treatment of Patients with abnormal scars.Measurement of the patient and their keloid formation in patients treated at the Surgery Clinic of the Institute of Clinical Specialist / PAM MARECHAL Juiz de Fora - MG.A10.165.450.300.425RBR-5gvsgpniversidade Presidente Antônio Carlos - Faculdade de Medicina de Juiz de Fora